tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PHAR Stock Latest News

Pharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital
The FlyPharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital
9d ago
PHAR
Pharming price target lowered to $30 from $31 at Oppenheimer
PremiumThe Fly
Pharming price target lowered to $30 from $31 at Oppenheimer
17d ago
PHAR
Is PHAR a Buy, Before Earnings?
PremiumPre-Earnings
Is PHAR a Buy, Before Earnings?
23d ago
PHAR
Pharming Group Delays Leniolisib EU Approval
PremiumCompany Announcements
Pharming Group Delays Leniolisib EU Approval
6M ago
6K
PHAR
Pharming Group Shareholders Approve Key Proposals
PremiumCompany Announcements
Pharming Group Shareholders Approve Key Proposals
6M ago
6K
PHAR
Pharming Group Announces Convertible Bonds Redemption
PremiumCompany AnnouncementsPharming Group Announces Convertible Bonds Redemption
6M ago
6K
PHAR
Pharming Group Boasts Strong Q1 Revenue Growth
Premium
Company Announcements
Pharming Group Boasts Strong Q1 Revenue Growth
6M ago
6K
PHAR
Pharming Group’s Strategic Financial Maneuver
Premium
Company Announcements
Pharming Group’s Strategic Financial Maneuver
7M ago
6K
PHAR
Pharming Group Lauded for Rare Disease Treatment
PremiumCompany Announcements
Pharming Group Lauded for Rare Disease Treatment
7M ago
6K
PHAR
Pharming Completes Trial Enrollment for Pediatric Drug
PremiumCompany Announcements
Pharming Completes Trial Enrollment for Pediatric Drug
7M ago
6K
PHAR
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
PremiumCompany Announcements
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
7M ago
PHAR
Pharming Group Files Annual Report, Sets AGM Date
PremiumCompany Announcements
Pharming Group Files Annual Report, Sets AGM Date
7M ago
6K
PHAR
Pharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
PremiumThe FlyPharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
8M ago
PHAR
PHAR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PHAR Earnings this Week: How Will it Perform?
8M ago
PHAR
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
Premium
The Fly
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
9M ago
PHAR
Pharming management to meet with Oppenheimer
PremiumThe Fly
Pharming management to meet with Oppenheimer
11M ago
PHAR
Pharming management to meet with Oppenheimer
PremiumThe Fly
Pharming management to meet with Oppenheimer
11M ago
PHAR
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
PremiumThe Fly
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
1y ago
PHAR
Pharming enrolls first patient in leniolisib trial in Japan
PremiumThe Fly
Pharming enrolls first patient in leniolisib trial in Japan
1y ago
PHAR
Pharming nominates Richard Peters to become chairman
PremiumThe FlyPharming nominates Richard Peters to become chairman
1y ago
PHAR
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
2y ago
PHAR
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
2y ago
PHAR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >